Posted in Business GSK to buy liver disease drug from Boston Pharmaceuticals for up to $2 billion Estimated read time 2 min read Posted on May 14, 2025 by Joelgalvan GSK will buy efimosfermin, a liver disease drug in late-stage trials, for up to $2 billion from U.S. biotechnology firm…
